Effects of Deanxit on type 2 diabetic patients with depressive symptom

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-16007715

Enrollment

Unknown

Registered

2016-01-04

Start date

2016-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus associated with emotional disorders

Interventions

2:Deanxit vs control

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. conform to the 2010 "Chinese type 2 diabetes prevention guide" in the diagnostic criteria for type 2 diabetes; 2. aged 18 to 70 years old; 3. there are symptoms of affective disorders, HAMD scores more than 17 or HAMA score 14 points; 4. With at least primary school education background; 5. informed consent.

Exclusion criteria

Exclusion criteria: 1. patients with type 1 diabetes and diabetic ketosis; 2. patients with severe liver and kidney function is not complete; 3. half a year have heart cerebrovascular accident or suicide; 4. taboo to Deanxit; 5. drug abusers, schizophrenia and patients with major depressive disorder; 6. acute infection, acute trauma, disease and perioperative patients with acute phase; 7. long-term use of antidepressants, anxiolytics and central excited drugs; 8. unwilling to cooperate.

Design outcomes

Primary

Measure	Time frame
;HbA1C;HAMD score;	—

Countries

China

Contacts

Public ContactYanjuan Zhu

pipalzhu@163.com+86 13042239114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026